A.S. was recently diagnosed with Hodgkin disease and scheduled for a staging procedure. His previous axillary lymph node biopsy result was positive for Reed-Sternberg cells. The surgeon charted results of the staging procedure as “stage I.” 2. How does Hodgkin lymphoma spread in the body, and what does “stage I” signify for A.S.?

A.S. was recently diagnosed with Hodgkin disease and scheduled for a staging procedure. His previous axillary lymph node biopsy result was positive for Reed-Sternberg cells. The surgeon charted results of the staging procedure as “stage I.” 2. How does Hodgkin lymphoma spread in the body, and what does “stage I” signify for A.S.?

Basic Clinical Laboratory Techniques 6E

6th Edition

ISBN:9781133893943

Author:ESTRIDGE

Publisher:ESTRIDGE

Chapter2: Basic Hematology

Section2.9: White Blood Cell Differential Count

Problem 15RQ

See similar textbooks

Similar questions

S.M.was recently diagnosed with Hodgkin disease and scheduled for a staging procedure. His previous axillary lymph node biopsy result was positive for Reed-Sternberg cells. The surgeon charted the results of the staging procedure as “stage I.” What is the purpose of the staging procedure for S.M.? (List 2 reasons for staging.) How does Hodgkin lymphoma spread in the body, and what does “stage I” signify for S.M.? (Describe how Hodgkin disease spreads and explain the meaning of “Stage I.”) What is the difference between Hodgkin disease and non-Hodgkin lymphoma? (Outline the primary difference, then outline the various pathophysiologic aspects of each disease., along with symptoms.) What is the prognosis and predicted therapy for S.M.now that he has been diagnosed with stage I Hodgkin disease? (List the 5 year survival rate of Hodgkin disease and outline the treatment plan for Stage I Hodgkin disease. Also, explain how the treatment would differ if it is discovered that…
A.S. was recently diagnosed with Hodgkin disease and scheduled for a staging procedure. His previous axillary lymph node biopsy result was positive for Reed-Sternberg cells. The surgeon charted results of the staging procedure as “stage I.” 3. What is the difference between Hodgkin disease and non-Hodgkin lymphoma?
A.S. was recently diagnosed with Hodgkin disease and scheduled for a staging procedure. His previous axillary lymph node biopsy result was positive for Reed-Sternberg cells. The surgeon charted the results of the staging procedure as “stage I.” What is the difference between Hodgkin disease and non-Hodgkin lymphoma? (Outline the primary difference, then outline the various pathophysiologic aspects of each disease., along with symptoms.) What is the prognosis and predicted therapy for A.S. now that he has been diagnosed with stage I Hodgkin disease? (List the 5 year survival rate of Hodgkin disease and outline the treatment plan for Stage I Hodgkin disease. Also, explain how the treatment would differ if it is discovered that A.S. actually has Stage II disease.) What side effects might A.S. expect from this therapy? (List at least 4 side effects.)
A.S. was recently diagnosed with Hodgkin disease and scheduled for a staging procedure. His previous axillary lymph node biopsy result was positive for Reed-Sternberg cells. The surgeon charted results of the staging procedure as “stage I.” 1. What is the purpose of the staging procedure for A.S.?
In a patient of 60 years old after the surgical removal of stomach cancer and subsequent treatment, an enlarged lymph node in the left supraclavicular area was detected. Atypical cells, which were similar to the cells of a previously removed tumor, were found after the biopsy of this lymph node, Questions: 6) Is kind of tumors (benign or malignant) is characterized by the presence of cellular atypism? 7) What are the characteristics of malignant tumors?
In detail, explain the difference between Hodgkin's Lymphoma and non-Hodgkin's Lymphoma.
In a patient of 60 years old after the surgical removal of stomach cancer and subsequent treatment, an enlarged lymph node in the left supraclavicular area was detected. Atypical cells, which were similar to the cells of a previously removed tumor, were found after the biopsy of this lymph node, Questions: 1) What typical pathological process (TPP) has developed in the lymph node? 2) Indicate the stages of this TPP. 3) Indicate possible ways of tumor cells spreading throughout the body.
Which is not characteristic of Hodgkin lymphoma in the following options A.randomness and uncertainty of the site of the disease B.lymph nodes are the primary source in about 90% of cases, the disease usually starts from one or a group of lymph nodes and gradually spreads to nearby lymph nodes C. tumor cells are a unique type of tumor giant cells, which only account for 1-5% of all cell components in the pathological tissues D. R-S cells in tumor tissues of different cases or in different pathological stages of the same case are different E. in the later stages of HL, the bone marrow may be involved in about 10% of cases
Why are the axillary lymph nodes often biopsied in cases of suspected breast cancer?
Leukemic lymphoma is when Question 3 options: A) Lymphoma cells have migrated into the peripheral blood B) Reed-Sternberg cells are present C) Burkitt's lymphoma is diagnosed D) non-Hodgkin lymphoma is diagnosed
A 42-year-old woman presents with an enlarged supraclavicular lymph node. The patient is HIV positive and takes antiviral medications. A lymph node biopsy is shown in the image. The tumor cells express B cell antigens and are positive for Epstein-Barr virus (EBV). Which of the following is the most likely diagnosis? (A) Follicular lymphoma (B) Hodgkin lymphoma (C) Large B-cell lymphoma (D) MALT lymphoma (E) Mantle cell lymphoma
A pathology report from a biopsy of an enlarged supraclavicular node reads, ‘Collagen bands extend from the node capsule to encircle nodules of abnormal tissue. A characteristic lacunar cell variant of the Reed–Sternberg cell is often found. Eosinophilia is frequent.’ Which ONE histological subtype of Hodgkin lymphoma is being described in this statement? Select one: A.Lymphocyte depleted B.Mixed cellularity C.Nodular sclerosing D.Lymphocyte predominant